EZ Breathe Atomizer Model # EZ-100. For the delivery of liquid medications for respiratory us...
FDA Device Recall #Z-1371-2013 — Class I — April 30, 2013
Recall Summary
| Recall Number | Z-1371-2013 |
| Classification | Class I — Serious risk |
| Date Initiated | April 30, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Nephron Pharmaceuticals Corp. |
| Location | Orlando, FL |
| Product Type | Devices |
| Quantity | 604 each |
Product Description
EZ Breathe Atomizer Model # EZ-100. For the delivery of liquid medications for respiratory usage.
Reason for Recall
Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard.
Distribution Pattern
Worldwide Distribution-USA (nationwide) including DC and Puerto Rico and the states of AL, AZ, CA, CO, CT, FL, IL, IN, IO, GA, KS, KY, LA, MD, MN, MS, MO, NK, NV, NJ, NM, NY, OH, OK, OR, PA, RI, SC, TN , TX, VT, VA, WA, and WV, and the countries of Guatemala, Poland, Panama, and United Kingdom.
Lot / Code Information
Model # EZ-100 Lots # R2029A, R2029B, R2039A, R2042A, R2045A, and R2047A. Atomizer Serial Number Ranges: 1206034476-1206069065 1207003710-1237038299 1207046505-1207081124 1208027421-1208062155 1209000001-1209069179 1209069180-1209069202 1209069203-1209069460 1210000001-1210103680 1210104001-1210104044
Other Recalls from Nephron Pharmaceuticals Corp.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2053-2016 | Class II | Sodium Chloride Inhalation Solution, USP 3%, 60... | Nov 16, 2015 |
| Z-2054-2016 | Class II | Sodium Chloride Inhalation Solution, USP 7%, 60... | Nov 16, 2015 |
| Z-1373-2013 | Class I | EZ Breathe Medication Cup. For the delivery ... | Apr 30, 2013 |
| Z-1372-2013 | Class I | AsthmaNefrin Starter Kit contains ten (10) Asth... | Apr 30, 2013 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.